Oncology-focused Beta Drugs raises Rs 117 crore from Healthquad, others - MSN
| BETA Stock | 2,124 38.55 1.85% |
Slightly above 55% of Beta Drugs' private investors are presently thinking to get in. The analysis of current outlook of investing in Beta Drugs suggests that some traders are interested regarding Beta Drugs' prospects. Beta Drugs' investing sentiment can be driven by a variety of factors including economic data, Beta Drugs' earnings reports, geopolitical events, and overall market trends.
Beta Drugs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Beta daily returns and investor perception about the current price of Beta Drugs as well as its diversification or hedging effects on your existing portfolios.
Beta |
Oncology-focused Beta Drugs raises Rs 117 crore from Healthquad, others MSN
Read at news.google.com
 |
Beta Drugs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beta Drugs stock to make a market-neutral strategy. Peer analysis of Beta Drugs could also be used in its relative valuation, which is a method of valuing Beta Drugs by comparing valuation metrics with similar companies.
Peers
Beta Drugs Related Equities
| DCBBANK | DCB Bank | 1.45 |
| ||
| KNRCON | KNR Constructions | 1.82 |
| ||
| DCMFINSERV | DCM Financial | 2.02 |
| ||
| MAHABANK | Bank of Maharashtra | 3.00 |
| ||
| UFO | UFO Moviez | 3.48 |
| ||
| UNIDT | United Drilling | 3.72 |
|
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.